Park West Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-95,868
Closed -$2.07M 70
2019
Q4
$2.07M Sell
95,868
-115,972
-55% -$2.66M 0.09% 69
2019
Q3
$4.79M Buy
+211,840
New +$5.87M 0.23% 60
2018
Q2
Sell
-498,559
Closed -$3.97M 112
2018
Q1
$3.97M Sell
498,559
-311,234
-38% -$1.92M 0.18% 74
2017
Q4
$5.94M Buy
+809,793
New +$5.05M 0.27% 66

Other funds holding CDNA

Park West Asset Management's CDNA Position: Q1 2020 in Review

Park West Asset Management sold out of CareDx (CDNA) in Q1 2020, closing a stake of 95,868 shares — an estimated $2.07M sold.

Park West Asset Management first reported a position in CDNA in Q4 2017 and held it in 4 quarters. The position peaked at $5.94M in Q4 2017. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.

  • Park West Asset Management reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
  • Park West Asset Management sold 95,868 CareDx shares in Q1 2020, an estimated $2.07M.
  • Park West Asset Management first reported a position in CareDx in Q4 2017 and held it in 4 quarters.
  • Park West Asset Management's CareDx position peaked at $5.94M in Q4 2017.
  • 144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.

Based on Park West Asset Management's 13F filing for Q1 2020, filed 15 May 2020.